PRESS CENTRE/LATEST INFORMATION
All information on our Company’s activities in one place

News

PRESS CENTAR / NEWS
Record semi-annual performance of Bosnalijek in 2022
In the first half of 2022, Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, made record profit before tax of BAM 20.7 million, an increase by BAM 18.9 million compared to the same period of the previous year. The profit is the result of the successfully implemented strategy and activities of the management and employees of Bosnalijek.
MORE
PRESS CENTAR / NEWS
Record semi-annual performance of Bosnalijek in 2022
In the first half of 2022, Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, made record profit before tax of BAM 20.7 million, an increase by BAM 18.9 million compared to the same period of the previous year. The profit is the result of the successfully implemented strategy and activities of the management and employees of Bosnalijek.
Read more
ANNUAL REGULAR ASSEMBLY
NOTICE OF CONVENING ANNUAL REGULAR ASSEMBLY OF BOSNALIJEK JSC
Pursuant to Article 48 paragraph (1) and (3) of Bosnalijek JSC Statute (consolidated text No: 2830/2017 of 18.09.2017) and Article 230 paragraph (1) of Company Law (Official Gazette of FB&H, No 81/15 and 75/21) and based on the Supervisory Board's Decision on Convening Annual Regular Assembly No: 3700/22 of 15 August 2022 we hereby announce:
Read more
Previous news
Notice on re-convening Regular Annual Shareholders Assembly of Bosnalij ... NOTICE ON CONVENING ANNUAL REGULAR ASSEMBLY OF BOSNALIJEK JSC NOTICE ON CONVENING AN EXTRAORDINARY SESSION OF THE GENERAL ASSEMBLY OF ... Notice on reconvening of regular annual shareholders’ Assembly of Bosnal ... Notice of convening annual regular assembly of Bosnalijek joint stock co ... REPORT BY VOTING COMMITTEE Notice of convening annual regular assembly of Bosnalijek d.d. Bosnalijek Opens New Facility for Manufacturing Liquid and Semisolid Pha ... Two Bosnalijek Teams Won Valuable Prizes at Dolorex B2B Night Relay Race ... Notice of convening annual regular assembly of Bosnalijek joint stock co ... Professional Lecture for Doctors and Patients Held On the Occasion of th ... Bosnalijek signs cooperation agreement with Mylan, a global healthcare c ... Bosnalijek Appoints US Major General David L. Grange (Ret.) as the Board ... The Third Congress of Pharmacists from Montenegro held in Bečići Foreign markets recognize the quality of our products Bosnalijek won the prestigious industry award Bosnalijek is again the best employer in the pharmaceutical sector in 20 ... Successful Two-Day Roundtable of Psychiatrists Held “Global Enterofuryl® Speaker Training – GEST” conference gathers nationa ... 4th “Acute Coronary Syndrome” training for 60 young doctors
novembar 26. 2022 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%